0
The European Union may give an initial green light in the coming days for sale of the drug remdesivir as a Covid-19 treatment, the head of its medicines agency said on Monday, fast-tracking the drug to market amid tight global competition for resources.
The United States, which has angered the EU with aggressive tactics in a procurement race during the global pandemic, has yet to issue a similar approval for the drug, made by US pharmaceutical company Gilead.
Read full story here.
